Charles River Laboratories International (CRL) Operating Income (2016 - 2025)
Historic Operating Income for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $133.8 million.
- Charles River Laboratories International's Operating Income rose 1396.36% to $133.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $140.9 million, marking a year-over-year decrease of 7330.93%. This contributed to the annual value of $227.3 million for FY2024, which is 6316.84% down from last year.
- As of Q3 2025, Charles River Laboratories International's Operating Income stood at $133.8 million, which was up 1396.36% from $100.1 million recorded in Q2 2025.
- Over the past 5 years, Charles River Laboratories International's Operating Income peaked at $187.4 million during Q2 2022, and registered a low of -$167.7 million during Q4 2024.
- Over the past 5 years, Charles River Laboratories International's median Operating Income value was $148.8 million (recorded in 2022), while the average stood at $126.0 million.
- Its Operating Income has fluctuated over the past 5 years, first surged by 7917.62% in 2021, then tumbled by 22615.44% in 2024.
- Over the past 5 years, Charles River Laboratories International's Operating Income (Quarter) stood at $172.8 million in 2021, then fell by 5.21% to $163.8 million in 2022, then fell by 18.86% to $132.9 million in 2023, then plummeted by 226.15% to -$167.7 million in 2024, then skyrocketed by 179.79% to $133.8 million in 2025.
- Its Operating Income was $133.8 million in Q3 2025, compared to $100.1 million in Q2 2025 and $74.7 million in Q1 2025.